Secretome Therapeutics

Secretome Therapeutics

This company develops regenerative cell therapies derived from neonatal cardiac progenitor cells for patients with heart failure and Duchenne muscular dystrophy associated cardiomyopathy.

Theratome Bio

This company develops stem-cell secretome therapeutics to treat ischemic brain injury, dry eye disease and organ transplant preservation for healthcare providers and patients.

Capricor

This biotechnology company develops cell and exosome-based therapies to treat Duchenne muscular dystrophy and other serious diseases for patients.

Soufflé Therapeutics

This biotechnology company develops cell-specific oligonucleotide therapies for patients with muscular dystrophy, heart failure, and metabolic disorders.

PacingCure

This biotechnology company develops precision gene therapies and biological pacemakers for patients suffering from cardiac rhythm disorders and heart failure.

Alder Therapeutics

This company develops allogeneic stem cell therapies to treat patients with retinitis pigmentosa and chronic heart failure.

Phlox Therapeutics

This company develops RNA-based gene therapies to treat patients with rare genetic heart diseases, including cardiomyopathies and laminopathies.

SE Therapeutics

This biotechnology firm develops self-delivering protein platforms for gene and cell therapy manufacturers treating chronic, rare and neurological diseases.